You are now leaving www.astellas.com/us. The website you are linking to is neither owned nor controlled by Astellas.
Astellas is not responsible for the content or services on this site.
Health is Our Passion and Priority
Astellas Pharma US is focused on providing safe and effective products that improve people's lives. We are committed to making a difference for our patients today and providing them with a brighter future tomorrow.
This commitment extends to providing resources for our patients and their physicians and caregivers that help them throughout the life cycle of their condition and beyond.
Below is a list of Astellas' products marketed in the U.S. This information is intended for U.S. residents only.
Lexiscan® (regadenoson) injection
ASTAGRAF XL® (tacrolimus extended-release capsules)
Prograf® (tacrolimus) capsules, granules and injection
AmBisome® (amphotericin B) liposome for injection
CRESEMBA® (isavuconazonium sulfate)
MYCAMINE® (micafungin for injection) for intravenous use
XTANDI® (enzalutamide) capsules
XOSPATA® (gilteritinib) tablets
PADCEV® (enfortumab vedotin-ejfv)
Myrbetriq® (mirabegron) extended-release tablets
VESIcare® (solifenacin succinate) tablets
VESIcare LSTM (solifenacin succinate) oral suspension
This information is intended for U.S. residents only.
All trademarks are Astellas’ except:
AmBisome is a registered trademark of Gilead Sciences, Inc.
1 Astellas Way, Northbrook, IL 60062, an affiliate of Astellas Pharma US, Inc.